Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites

Biochemistry

Volumn 43, Issue 20, 2004, Pages 6219-6229

  Brown, W Michael ^a   Yowell, Charles A ^d   Hoard, Anna ^a   Vander Jagt, Thomas A ^a   Hunsaker, Lucy A ^a   Deck, Lorraine M ^b   Royer, Robert E ^a   Piper, Robert C ^c   Dame, John B ^d   Makler, Michael T ^e   Vander Jagt, David L ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e Flow Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINETRIPHOSPHATE; AMINO ACIDS; DISEASES; DRUG PRODUCTS; ENZYME KINETICS; METABOLISM;

LACTATE DEHYDROGENASE (LDH); MALARIAL PARASITES;

PROTOZOA;

3 ACETYLPYRIDINE; ADENOSINE TRIPHOSPHATE; ENZYME INHIBITOR; LACTATE DEHYDROGENASE; LACTIC ACID; LIGAND; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROLINE; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; COMPARATIVE STUDY; CRYSTAL STRUCTURE; DISSOCIATION CONSTANT; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME STRUCTURE; GLYCOLYSIS; MICHAELIS CONSTANT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; COENZYMES; HUMANS; HYDROGEN-ION CONCENTRATION; L-LACTATE DEHYDROGENASE; LACTIC ACID; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PLASMODIUM; PROTOZOAN PROTEINS; PYRUVIC ACID; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PROTOZOA;

EID: 2442695378     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049892w     Document Type: Article

References (48)

1. Krogstad, D. J. (1996). Malaria as a reemerging disease, Epidemiol. Rev. 18, 77-89.
2. Barat, L. M., and Bloland, P. B. (1997). Drug resistance among malaria and other parasites, Infect. Dis. Clin. North Am. 11, 969-987.
3. Vander Jagt, D. L., Hunsaker, L. A., Campos, N. M., and Baack, B. R. (1990) D-Lactate formation in human erythrocytes infected with Plasmodium falciparum, Mol. Biochem. Parasitol. 42, 277-284.
4. Scheibel, L. W., and Pflaum, W. K. (1970) Carbohydrate metabolism in Plasmodium knowlesi, Comp. Biochem. Physiol. 37, 543-553.
5. Sherman, I. W. (1979) Biochemistry of Plasmodium (malaria parasites), Microbiol. Rev. 43, 453-495.
6. Certa, U., Ghersa, P., Dobeli, H., Matile, H., Kocher, H. P., Shrivastava, I. K., Shaw, A. R., and Perin, L. H. (1988). Aldolase Activity in a Plasmodium falciparum protein with protective properties, Science 240, 1036-1038.
7. Kaslow, D. C., and Hill, S. (1990). Cloning metabolic pathway genes by complementation in Escherichia coli: Isolation and expression of Plasmodium falciparum glucose phosphate isomerase, J. Biol. Chem. 265, 12337-12341.
8. Hicks, E., Read, M., Holloway, S. P., Sims, P. F. G., and Hyde, J. E. (1991). Glycolytic pathway of the human malaria parasite Plasmodium falciparum: Primary sequence analysis of the gene encoding 3-phosphoglycerate kinase and chromosomal mapping studies, Gene 100, 123-129.
9. Olafsson, P., Matile, H., and Certa, U. (1992). Molecular analysis of Plasmodium falciparum hexokinase, Mol. Biochem. Parasitol. 56, 89-102.
10. Daubenberger, C. A., Poltl-Frank, F., Jiang, G., Lipp, J., Certa, U., and Pluschke, G. (2002) Identification and recombinant expression of glyceraldehydes-3-phosphate dehydrogenase of Plasmodium falciparum, Gene 246, 255-264.
11. Read, M., Hicks, K. E., Sims, P. F. G., and Hyde, J. E. (1994). Molecular characterisation of the enolase gene from the malaria parasite Plasmodium falciparum. Evidence for ancestry within a photosynthetic lineage, Eur. J. Biochem. 220, 513-520.
12. Ranie, J., Kumar, V. P. H., and Balaram, H. (1993). Cloning of the triose-phosphate isomerase gene of Plasmodium falciparum and expression in Escherichia coli, Mol. Biochem. Parasitol. 61, 159-169.
13. Bzik, D. J., Fox, B. A., and Gonyer, K. (1993). Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli, Mol. Biochem. Parasitol. 59, 155-166.
14. Dunn, C. R., Banfield, M. J., Barker, J. J., Higham, C. W., Moreton, K. M., Brady, R. L., and Holbrook, J. J. (1996) The structure of lactate dehydrogenase from Plasmodium faciparum reveals a new target for anti-malarial design, Nat. Struct. Biol. 3, 912-915.
15. Velanker, S. S., Ray, S. S., Gokhale, R. S., Suma, S., Balaram, H., Balaram, P., and Murthy, M. R. (1997). Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design, Structure 5, 751-761.
16. Kim, H., Certa, U., Dobeli, H., Jakob, P., and Hol, W. G. (1998). Crystal structure of fructose-1,6-bisphosphate aldolase from the human malaria parasite Plasmodium falciparum, Biochemistry 31, 4388-4396.
17. Vander Jagt, D. L., Hunsaker, L. A., and Heidrich, J. E. (1981). Partial purification and characterization of lactate dehydrogenase from Plasmodium falciparum, Mol. Biochem. Parasitol. 4, 255-264.
18. Dunn, C. R., Wilks, H. M., Halsall, D. J., Atkinson, T., Clarke, A. R., Muirhead, H., and Holbrook, J. J. (1991). Design and synthesis of new enzymes based on the lactate dehydrogenase framework, Philos. Trans. R. Soc. London B 332, 177-184.
19. Royer, R. E., Deck, L. M., Campos, N. M., Hunsaker, L. A., and Vander Jagt, D. L. (1986). Biologically active derivatives of gossypol: Synthesis and antimalarial activities of peri-acylated gossylic nitriles, J. Med. Chem. 29, 1799-1801.
20. Deck, L. M., Royer, R. E., Chamblee, B. B., Hernandez, V. M., Malone, R. R., Torres, J. E., Hunsaker, L. A., Piper, R. C., Makler, M. T., and Vander Jagt, D. L. (1998). Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum, J. Med. Chem. 41, 3879-3887.
21. Remington, J. S., and Desmonts, G. Toxoplasmosis. In Infectious Diseases of the Fetus and Newborn Infant (Remington, J. S., and Klein, J. O., Eds.) pp 89-195, WB Saunders and Co., Philadelphia, 1990.
22. Roos, D. S., Crawford, M. J., Donald, R. G., Fohl, L. M., Hager, K. M., Kissinger, J. C., Reynolds, M. G., Striepen, B., and Sullivan, W. J., Jr. (1999). Transport and trafficking: Toxoplasma as a model for Plasmodium, Novartis Found. Symp. 226, 176-195.
23. Waller, R. F., Keeling, P. J., Donald, R. G., Striepen, B., Handman, E., Lang-Unnasch, N., Cowman, A. F., Besra, G. S., Roos, D. S., and McFadden, G. I. (1998) Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum, Proc. Natl. Acad. Sci. 95, 12352-12357.
24. Dzierszinski, F., Popescu, O., Toursel, C., Slomianny, C., Yahiaoui, B., and Tomavo, S. (1999). The protozoan parasite Toxoplasma gondii expresses two functional plant-like glycolytic enzymes. Implications for evolutionary origin of apicomplexans, J. Biol. Chem. 274, 24888-24895.
25. Yang, S., and Parmley, S. F. (1995). A bradyzoite stage-specifically expressed gene of Toxoplasma gondii encodes a polypeptide homologous to lactate dehydrogenase, Mol. Biochem. Parasitol. 73, 291-294.
26. Yang, S., and Parmley, S. F. (1997). Toxoplasma gondii expresses two distinct lactate dehydrogenase homologous genes during its lifecycle in intermediate hosts, Gene 184, 1-12.
27. Dando, C., Schroeder, E. R., Hunsaker, L. A., Deck, L. M., Royer, R. E., Zhou, X., Parmley, S. F., and Vander Jagt, D. L. (2001). The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH-1 and LDH-2) from Toxoplasma gondii: Comparison with pLDH from Plasmodium falciparum, Mol. Biochem. Parasitol. 118, 23-32.
28. Hewitt, C. O., Eszes, C. M., Sessions, R. B., Moreton, K. M., Dafforn, T. R., Takei, J., Dempsey, C. E., Clarke, A. R., and Holbrook, J. J. (1999). A general method for relieving substrate inhibition in lactate dehydrogenases, Protein Eng. 12, 491-496.
29. Gomez, M. S., Piper, R. C., Hunsaker, L. A., Royer, R. E., Deck, L. M., Makler, M., and Vander Jagt, D. L. (1997) Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum, Mol. Biochem. Parasitol. 90, 235-246.
30. Sali, A., and Blundell, T. (1993). Comparative protein modeling by satisfaction of spatial restraints, J. Mol. Biol. 234, 779-815.
31. McLachlan, A. D. (1982). Rapid comparison of protein structures, Acta Crystallogr. Sect. A-Found. Crystallogr. 38, 871-873.
32. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures, J. Appl. Crystallogr. 26, 283-291.
33. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated docking using a Lamarkian genetic algorithm and empirical binding free energy function, J. Comput. Chem. 19, 1639-1662.
34. Yu, Y., Deck, J. A., Hunsaker, L. A., Deck, L. M., Royer, R. E., Goldberg, E., and Vander Jagt, D. L. (2001) Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4, Biochem. Pharmacol. 61, 81-89.
35. Makler, M. T., Ries, J. A., Williams, J. E., Bancroft, R. C., Piper, B. L., Gibbins, B. L., and Hinrichs, D. J. (1993) Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity, Am. J. Trop. Med. Hyg. 48, 739-741.
36. Makler, M. T., and Hinrichs, D. J. (1993) Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia, Am. J. Trop. Med. Hyg. 48, 205-210.
37. Vander Jagt, D. L., Deck, L. M., and Royer, R. E. (2000) Gossypol: prototype of inhibitors targeted to dinucleotide folds, Curr. Med. Chem. 7, 479-498.
38. Brooks, B., Bruccoleri, R., Olafson, B., States, D., Swaminathan, S., and Karplus, M. (1983) CHARMM-a program for macromolecular energy, minimization, and dynamics calculations, J. Comput. Chem. 4, 187-217.
39. Zhu, G., and Keithly, J. S. (2002) α-Proteobacterial relationships of apicomplexan lactate and malate dehydrogenases, J. Eukaryot. Microbiol. 49, 255-261.
40. Wilks, H. M., Hart, K. W., Feeney, R., Dunn, C. R., Muirhead, H., Chia, W. N., Barstow, D. A., Atkinson, T., Clarke, A. R., and Holbrook, J. J. (1988) A specific, highly active malate dehydrogenase by redesign of the lactate dehydrogenase framework, Science 242, 1541-1544.
41. Wilks, H. M., Moreton, K. M., Halsall, D. J., Hart, K. W., Sessions, R. D., Clarke, A. R., and Holbrook, J. J. (1992) Design of a specific phenyllactate dehydrogenase by peptide loop exchange on the Bacillus stearothermophilus lactate dehydrogenase framework, Biochemistry 31, 7802-7806.
42. Madern, D. (2002) Molecular evolution within the L-malate and L-lactate dehydrogenase superfamily, J. Mol. EvoL 54, 825-840.
43. + use, Biochemistry 43, 879-889.
44. Eszes, C. M., Sessions, R. B., Clark, A. R., Moreton, K. M., and Holbrook, J. J. (1996) Removal of substrate inhibition in a lactate dehydrogenase from human muscle by a single residue change, FEBS Lett. 399, 193-197.
45. Wigley, D. B., Gamblin, S. J., Turkenburg, J. P., Dodson, E. J., Piontek, K., Muirhead, H., and Holbrook, J. J. (1992) Structure of a ternary complex of an allosteric lactate dehydrogenase from Bacillus stearothermophilus at 2.5 A resolution, J. MoL Biol. 223, 317-335.
46. Parasrampuria, D. A., de Boer, P., Desai-Krieger, D., Chow, A. T., and Jones, C. R. (2003) Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study, J. Clin. Pharmacol. 43, 406-413.
47. Winter, V. J., Cameron, A., Tranter, R., Sessions, R. B., and Brady, R. L. (2003) Crystal structure of Plasmodium berghei lactate dehydrogenase indicates the unique structural differences of these enzymes are shared across the Plasmodium genus, Mol. Biochem. Parasitol. 131, 1-10.
48. Read, J. A., Winter, V. J., Eszes, C. M., Sessions, R. B., and Brady, R. L. (2001) Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase, Proteins 43, 175-185.